CA
NZ
UK
AU
IND
US
Teladoc Health, Inc. (NYSE:TDOC) shares fell 2.54% today to $6.34 after the company announced the immediate appointment of Michael Grasher as Chief Financial Officer. The leadership change was framed by management as part of a broader strategy aimed at delivering disciplined, sustainable growth.
Apnimed, Inc. (NASDAQ:APMD) shares fell 12.39% today to $26.03, giving back much of the rally recorded last week that followed a bullish coverage initiation from a major research firm, which had assigned a buy rating and a $41 price target implying substantial upside for …
BioVie Inc. (NASDAQ:BIVI) shares rose 13.43% today to $2.45 after the company announced completion of the last on-treatment visit in its Phase 2 ADDRESS-LC trial evaluating bezisterim for neurological symptoms associated with Long COVID. The company said it anticipates announcing topline results before the …
Trinity Biotech plc (NASDAQ:TRIB) shares ticked up today to $9.85 even as the company disclosed it had received a staff determination letter from Nasdaq stating it had not regained compliance with the minimum market value of publicly held shares requirement by its August 18, …
Ascendis Pharma A/S (NASDAQ:ASND) shares rose 6.87% today to $264.93 after the company announced a binding term sheet for a global settlement and license agreement with BioMarin Pharmaceutical Inc. related to YUVIWEL and navepegritide-related products. The agreement resolves all outstanding litigation and disputes between …
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) shares rose 2.84% today to $251.50 after the company announced second interim overall survival results from the Phase 3 HERIZON-GEA-01 trial, showing that Ziihera in combination with chemotherapy achieved a statistically significant and clinically meaningful overall survival benefit compared with …
60 Degrees Pharmaceuticals (NASDAQ:SXTP), trading as aPenny Stockat $1.03, fell 2.83% at last closing. The small specialty pharmaceutical company focused on infectious and vector-borne diseases grew its modest productRevenuein the second quarter but operates with heavy losses, minimal revenue, substantial dilution and an explicit …
Evogene (NASDAQ:EVGN), trading as aPenny Stockat $0.55, rose 2.16% at last closing. The company that has pivoted to focus on AI-driven computational chemistry for drug and product discovery narrowed its net loss and sharply reduced its cash burn in the second quarter after streamlining …
● Prestige reported fiscal 2027 first-quarterRevenueof about $265.7 million, up about 6.5% year over year, withOrganic Salesup about 3.2%.
● ProKidney has aligned with the FDA on an accelerated-approval pathway for rilparencel, its cell therapy for diabetic chronic kidney disease.
Please wait processing your request...